Ikena Oncology (IKNA)
(Delayed Data from NSDQ)
$1.67 USD
-0.01 (-0.60%)
Updated Jul 24, 2024 04:00 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Ikena Oncology, Inc. [IKNA]
Reports for Purchase
Showing records 1 - 20 ( 33 total )
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Strategic Reprioritization Leaves a MAP "K" Towards Value; Reit. Buy and Lowering Our PT to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Continuing to Execute with Optimized IK-930 Data Soon
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Come Together (RAF/MEK), Right Now, Over Me (IK-595) - KOL Insights on Recent Competitor Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
New Improved IK-930 Formulation Looks to Forge a Path in EHE and Mesothelioma With Data in 2H24
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Ikena?s Refined Focus on IK-930 IK-595, Shape a Standout Precision Oncology Play
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Positive IK-930 Update, Draws Investor Overreaction; Reit Buy and Lowering Our PT to $11
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- 2023 Small Molecule Precision Oncology Review and Outlook
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
EORTC-NCI-AACR 2023: Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- EORTC-NCI-AACR 2023 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Ikena Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Under-the-Radar Themes From the 5th Annual RAS-Targeting Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A